Business Description
This fund puts at least 90% of its money into stocks that make up its benchmark index, which tracks U.S. companies working in biotechnology and genomics. These businesses focus primarily on creating, producing, and selling biotech-related products and services. The fund is non-diversified, meaning it may hold a concentrated number of positions.
